» Articles » PMID: 21296564

Medical Exposure to Radiation and Thyroid Cancer

Overview
Specialty Oncology
Date 2011 Feb 8
PMID 21296564
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

In 2008, the worldwide estimated age-standardised incidence rates for thyroid cancer incidence were 4.7 and 1.5 per 100,000 women and men, respectively. Thyroid cancer's overall contribution to the worldwide cancer burden is relatively small, but incidence rates have increased over the last three decades throughout the world. This trend has been hypothesised to reflect a combination of technological advances enabling increased detection, but also changes in environmental factors, including population exposure to ionising radiation from fallout, diagnostic tests and treatment for benign and malignant conditions. Studies of the atomic bomb survivors and populations treated with radiotherapy have established radiation as a risk factor for thyroid cancer, particularly from early life exposure. About 0.62 mSv (20%) of the global annual per caput effective radiation dose comes from diagnostic medical and dental radiation for the period of 1997-2007, increased from 0.4 mSv for the years 1991-1996. This international trend of increasing population exposure to medical diagnostic sources of radiation, attributed in large part to the growing use of computed tomography scans, but also interventional radiology procedures, has raised concerns about exposure to radiosensitive organs such as the thyroid. Worldwide, medical and dental X-rays constitute the most common type of diagnostic medical exposures, but their contribution to the cumulative effective dose is relatively low, whereas computed tomography scans account for 7.9% of diagnostic radiology examinations but 47% of the collective effective dose from diagnostic radiation procedures in parts of the world. Although the radiation exposure from computed tomography scans is substantially lower than that from radiotherapy, multiple computed tomography scans could result in non-trivial cumulative doses to the thyroid. Studies are currently underway to assess the incidence of cancer in large cohorts of children who received computed tomography scans. National and international efforts have been developed to raise awareness and to standardise procedures for use of computed tomography and interventional radiology procedures in paediatric and general populations.

Citing Articles

Global burden of thyroid cancer in adolescents and young adults (aged 15-39 years) from 1990 to 2021: A systematic analysis of the Global Burden of Disease Study 2021.

Qiu Z, Yu S, Zheng L, Lou Y, Chen X, Xuan F PLoS One. 2025; 20(2):e0318605.

PMID: 39951481 PMC: 11828416. DOI: 10.1371/journal.pone.0318605.


Estimation and comparison of the effective dose and lifetime attributable risk of thyroid cancer between males and females in routine head computed tomography scans: a multicentre study.

Khoramian D, Haghparast M, Honardari A, Nouri E, Ranjbar E, Abedi-Friouzjah R J Med Radiat Sci. 2024; 71(2):240-250.

PMID: 38216155 PMC: 11177018. DOI: 10.1002/jmrs.752.


Secular trends of morbidity and mortality of thyroid cancer in five Asian countries from 1990 to 2019 and their predictions to 2035.

Tang S, Zi H, Tao H, Huang Q, Guo X, Deng T Thorac Cancer. 2023; 14(36):3540-3548.

PMID: 37941298 PMC: 10733153. DOI: 10.1111/1759-7714.15160.


Impact of simulated reduced injected dose on the assessment of amyloid PET scans.

Young P, Heeman F, Axelsson J, Collij L, Hitzel A, Sanaat A Eur J Nucl Med Mol Imaging. 2023; 51(3):734-748.

PMID: 37897616 PMC: 10796642. DOI: 10.1007/s00259-023-06481-0.


Radiation-Related Thyroid Cancer.

Saenko V, Mitsutake N Endocr Rev. 2023; 45(1):1-29.

PMID: 37450579 PMC: 10765163. DOI: 10.1210/endrev/bnad022.